Investigational Drug Information for ASN002
✉ Email this page to a colleague
What is the drug development status for ASN002?
ASN002 is an investigational drug.
There have been 7 clinical trials for ASN002.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 29th 2018.
The most common disease conditions in clinical trials are Dermatitis, Eczema, and Dermatitis, Atopic. The leading clinical trial sponsors are Asana BioSciences and [disabled in preview].
There are five US patents protecting this investigational drug and thirty international patents.
Summary for ASN002
| US Patents | 5 |
| International Patents | 30 |
| US Patent Applications | 16 |
| WIPO Patent Applications | 11 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2018-09-29) |
| Vendors | 21 |
Recent Clinical Trials for ASN002
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema | Asana BioSciences | Phase 2 |
| Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects | Asana BioSciences | Phase 1 |
| Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis | Asana BioSciences | Phase 2 |
Clinical Trial Summary for ASN002
Top disease conditions for ASN002
Top clinical trial sponsors for ASN002
US Patents for ASN002
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ASN002 | ⤷ Try a Trial | Pyrimido-pyridazinone compounds and methods of use thereof | Asana BioSciences, LLC (Lawrenceville, NJ) | ⤷ Try a Trial |
| ASN002 | ⤷ Try a Trial | Uses of pyrimido-pyridazinones to treat cancer | Asana BioSciences, LLC (Lawrenceville, NJ) | ⤷ Try a Trial |
| ASN002 | ⤷ Try a Trial | Pyrimido-pyridazinone compounds and methods of use thereof | Asan BioSciences, LLC (Lawrenceville, NJ) | ⤷ Try a Trial |
| ASN002 | ⤷ Try a Trial | Pyrimido-pyridazinone compounds and methods of use thereof | Endo Pharmaceuticals Inc. (Malvern, PA) | ⤷ Try a Trial |
| ASN002 | ⤷ Try a Trial | Pyrimido-pyridazinone compounds and methods of use thereof | Asana Biosciences, LLC (Bridgewater, NJ) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ASN002
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ASN002 | Brazil | BR112014003981 | 2031-08-23 | ⤷ Try a Trial |
| ASN002 | Canada | CA2846187 | 2031-08-23 | ⤷ Try a Trial |
| ASN002 | China | CN103974955 | 2031-08-23 | ⤷ Try a Trial |
| ASN002 | China | CN108707151 | 2031-08-23 | ⤷ Try a Trial |
| ASN002 | Denmark | DK2748166 | 2031-08-23 | ⤷ Try a Trial |
| ASN002 | European Patent Office | EP2748166 | 2031-08-23 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
